MGZ Medizinisch Genetisches Zentrum

Congenital Cataract Facial Dysmorphism Neuropathy Syndrome, CCFDN - CTDP1

CTDP1

Klinische Symptomatik

Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN Syndrome) is a rare autosomal recessive disease that has thus far only been described for the Roma population. Affected patients exhibit a complex clinical phenotype involving multiple organs. This includes congenital cataracts, microcorneae, hypomyelinating peripheral neuropathy, dwarfism, facial dysmorphism, and delayed psychomotor development. Parainfectious rhabdomyolysis can become a serious complication; the risk of complications under general anaesthesia is also heightened. Cataract surgery is recommended early on in order to prevent long-lasting impairment of vision.

Genetik

CCFDN Syndrome is caused by a mutation in the CTDP1 gene (C-terminal domain of RNA Polymerase II subunit A) located on chromosome 18q23. The known mutation is an intronic founder mutation (c.863+389 C>T, Leu287fs) in intron 6.

RT-PCR and sequence analysis has revealed the rare mechanism of aberrant splicing. The donor site created by a C>T transition activates a cryptic acceptor site located upstream, through which 95 nucleotides in an alu element are inserted into the processed CTDP1 mRNA.

CCFDN Syndrome follows an autosomal recessive pattern of inheritance.

Häufigkeit

Rare, though common among Roma.

 

Diagnostik

 

Indikation

The above mentioned symptoms.

Methodik

Targeted testing for the mutation (c.863+389 C>T) by DNA sequencing of the corresponding region in inton 6 of the CTDP1 gene. If test results are negative and clinical suspicion remains, complete sequencing is available.

Material

2 - 4 ml of EDTA blood

Dauer

4 - 6 weeks

Versand

Mail at room temperature or lab-based courier.

Beratung

For genetic counselling please call +49 (0)89/309 08 86-0.





MGZ
Medizinisch Genetisches Zentrum

Bayerstraße 3-5 (durch die Mathäser-Passage)

Eingang Schlosserstraße 6
80335 München
info@mgz-muenchen.de
Tel. +49 (0)89/30 90 886-0
Fax +49 (0)89/30 90 886-66

Ärztliche Leitung
Prof. Dr. med. Dipl. chem. Elke Holinski-Feder